You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
COVID and Immunotherapy
480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

AbstractFullPdf
Nov 2020234018
Dec 20204107
Jan 202167010
Feb 202172010
Mar 202110209
Apr 202196010
May 20213907
Jun 2021107
Jul 20210011
Aug 20211019
Sep 2021005
Oct 202152019
Nov 202154012
Dec 20214606
Jan 20228606
Feb 20226609
Mar 202282015
Apr 20228003
May 202270014
Jun 202240010
Jul 20226204
Aug 202211207
Sep 2022176018
Oct 202215407
Nov 20225603
Dec 20225408
Jan 202368010
Feb 20234802
Mar 20233604
Apr 20231204
May 20232803
Jun 20232802
Jul 20231808
Aug 2023602
Sep 20232000
Oct 20233206
Nov 20236403
Dec 20234602
Jan 20241601
Feb 20242402
Mar 202426051
Total23150354